Skip to main content

Betty Woods, David Rutledge, Jay Johnston, Gerard Vaillant, and Mark Allen


Beckman Coulter has named Betty Woods non-executive chairman, the company said last week.

Woods, who is an 11-year veteran of the Beckman Coulter board, will succeed retiring executive chairman John Wareham. Woods is former president and CEO of Premera Blue Cross, and CEO of Premera, its holding company. She has been a member of the Beckman Coulter board since 1994. She is currently chair of the organization and compensation committee, Beckman said.

David Rutledge has been named chief financial officer at Southern Research Institute.

Rutledge has been with SRI for 19 years, serving as the company’s controller for the last seven years, SRI said. He joined SRI in 1986 as a contracts specialist.

Luminex said last week that its board of directors has appointed Jay Johnston and Gerard Vaillant to the board to serve as Class II and Class I directors, respectively. In addition, Luminex said that current board members Laurence Hirsch and Thomas Caskey will retire from the board.

Johnston currently serves as chairman of QuesTek Innovations. From 1975 to 1999, he held various positions at Abbott Laboratories, most recently as corporate vice president for diagnostic assays and systems. He holds an MBA in general management from Amos Tuck School of Business Administration.

Vaillant held a number of positions with Johnson & Johnson from 1981 to 2004, Luminex said. He has also served as chairman for Ortho-Clinical Diagnostics, Veridex, and Therakos. He currently serves on the board of directors for Sensors for Medicine and Science and Tecan.

Mark Allen has been promoted to senior vice president and managing director of Tripos Discovery Research, a UK-based unit of Tripos, the St. Louis-based company said last week. He used to be vice president of operations. Allen succeeds Peter Hecht, who is leaving Tripos to become CEO of Oridis Biomed. Hecht will remain a scientific advisor to the company.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.